Prognostic implication of erector spinae muscles in non‐small‐cell lung cancer patients treated with immuno‐oncology combinatorial chemotherapy-Reference-Cited by-同舟云学术

Prognostic implication of erector spinae muscles in non‐small‐cell lung cancer patients treated with immuno‐oncology combinatorial chemotherapy

Published:2021-10-02 Issue:21 Volume:12 Page:2857-2864
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Araki Taisuke¹,Kitaguchi Yoshiaki¹^ORCID,Suzuki Yusuke¹,Komatsu Masamichi¹,Sonehara Kei¹^ORCID,Wada Yosuke¹,Tateishi Kazunari¹^ORCID,Hanaoka Masayuki¹

Affiliation:

1. First Department of Internal Medicine Shinshu University School of Medicine Matsumoto City Japan

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.14142

Reference34 articles.

1. Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study

2. Patient‐reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non‐squamous non‐small‐cell lung cancer (KEYNOTE‐189): a multicentre, double‐blind, randomised, placebo‐controlled, phase 3 trial;Garassino MC;Lancet Oncol,2020

3. A Randomized, Placebo-Controlled Trial of Pembrolizumab Plus Chemotherapy in Patients With Metastatic Squamous NSCLC: Protocol-Specified Final Analysis of KEYNOTE-407

4. Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial

5. Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Muscle mass cross-sectional area is associated with survival outcomes in malignant pleural disease related to lung cancer;Respiratory Medicine;2023-10

2. Reduced volume and altered composition of paraspinal muscles in Marfan syndrome: A retrospective cohort study;Medicine;2023-09-29

3. Predictive value of the prognostic nutritional index in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis;Heliyon;2023-08

4. Imaging to predict checkpoint inhibitor outcomes in cancer. A systematic review;European Journal of Cancer;2022-11